Global Cell Line Development Market

$2,600.00

产品代码: GB02402R 行业: 地区:

Cell line development is a major step for examining the efficiency of drug discovery, toxicity and in vitro testing. It reduces time, effort and cost, which minimises the chance of research drugs failing at the clinical trial stage. The global cell line development market size is projected to grow by USD 5 十亿来自 2022 到 2028, 复合年增长率为 11.7 百分, 根据 Gen Consulting 公司的一份新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global cell line development market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the cell line development industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, source, 类型, 应用, 和地区. The global market for cell line development can be segmented by product: 设备, media and reagents. The media and reagents segment was the largest contributor to the global cell line development market in 2021. Cell line development market is further segmented by source: mammalian, non-mammalian. 据研究, the mammalian segment had the largest share in the global cell line development market. Based on type, the cell line development market is segmented into: continuous cell lines, hybridomas, primary cell lines, recombinant cell lines. 根据应用, the cell line development market also can be divided into: bioproduction, 药物发现, 组织工程, 其他的. Cell line development market by region is categorized into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

副产品:
– 设备
media and reagents

按来源:
mammalian
non-mammalian

按类型:
continuous cell lines
hybridomas
primary cell lines
recombinant cell lines

按申请:
bioproduction
– 药物发现
– 组织工程
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The report explores the recent developments and profiles of key vendors in the Global Cell Line Development Market, including BioFactura, 公司, 康宁公司, Fujifilm Diosynth Biotechnologies, 通用电气医疗集团, Horizon Discovery Group plc, LakePharma, 公司. (Curia Global, 公司), 龙沙集团公司, 默克公司, Rentschler Biopharma SE, Sartorius AG, Selexis SA (JSR公司), 赛默飞世尔科技公司, WuXi AppTec Co., 有限公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global cell line development market.
To classify and forecast the global cell line development market based on product, source, 类型, 应用, 地区.
To identify drivers and challenges for the global cell line development market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global cell line development market.
To identify and analyze the profile of leading players operating in the global cell line development market.

为什么选择这份报告
Gain a reliable outlook of the global cell line development market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Cell Line Development Market

对这份报告感兴趣? 立即获取免费样品!
Global Cell Line Development Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

11.7%

页数

89

行业参与者

BioFactura Inc., 康宁公司, Fujifilm Diosynth Biotechnologies, 通用电气医疗集团, Horizon Discovery Group plc, LakePharma Inc. (Curia Global Inc.), 龙沙集团公司, 默克公司, Rentschler Biopharma SE, Sartorius AG, Selexis SA (JSR公司), 赛默飞世尔科技公司, WuXi AppTec Co. 有限公司.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Cell Line Development Market

请填写我们的表格,我们会尽快回复您.